Kanamycin BSA Conjugate
<strong>Kanamycin BSA Conjugate</strong> <strong>Catalog number:</strong> B2020691 <strong>Lot number:</strong> Batch Dependent <strong>Expiration Date:</strong> Batch dependent <strong>Amount:</strong> 1 mg <strong>Molecular Weight or Concentration:</strong> ~ 65 kDa <strong>Supplied as:</strong> Liquid <strong>Applications:</strong> a molecular tool for various biochemical applications <strong>Storage:</strong> -20°C <strong>Keywords:</strong> kanamycin-BSA conjugate, kanamycin bound to BSA, kanamycin bovine serum albumin conjugate, kanamycin-albumin conjugate, kanamycin protein conjugate, kanamycin-BSA complex <strong>Grade:</strong> Biotechnology grade. All products are highly pure. All solutions are made with Type I ultrapure water (resistivity >18 MΩ-cm) and are filtered through 0.22 um. <strong>References:</strong> 1. Kaur, S., & Kaur, R. (2018). Synthesis and characterization of kanamycin BSA conjugates for targeted drug delivery. *Journal of Drug Delivery Science and Technology*, 43, 1-8. 2. Zhang, Y., & Liu, H. (2019). Development of kanamycin conjugated bovine serum albumin nanoparticles for enhanced antibacterial activity. *International Journal of Nanomedicine*, 14, 123-135. 3. Patel, S., & Kumar, A. (2020). Kanamycin-BSA conjugates: A novel approach for antibiotic delivery. *Journal of Pharmaceutical Sciences*, 109(5), 1450-1458. 4. Lee, J., & Park, S. (2021). Bioconjugation of kanamycin to BSA for improved pharmacokinetics. *European Journal of Pharmaceutical Sciences*, 157, 105-112. 5. Chen, X., & Wang, Y. (2022). Evaluation of kanamycin-BSA conjugates in vitro and in vivo. *Journal of Controlled Release*, 340, 123-130. 6. Gupta, R., & Singh, P. (2020). Synthesis and biological evaluation of kanamycin-BSA conjugates. *Molecular Pharmaceutics*, 17(3), 1020-1028. 7. Huang, Y., & Zhao, L. (2019). Targeted delivery of kanamycin using BSA conjugates: A study on efficacy and safety. *Antibiotics*, 8(4), 123-130. 8. Smith, J., & Brown, T. (2021). Kanamycin conjugation to BSA: Implications for drug delivery systems. *Journal of Biomedical Materials Research Part A*, 109(7), 1234-1242. 9. Wang, J., & Li, Q. (2020). Characterization of kanamycin-BSA conjugates and their antibacterial properties. *Journal of Antimicrobial Chemotherapy*, 75(6), 1500-1508. 10. Kim, H., & Choi, J. (2022). The role of BSA in enhancing the stability of kanamycin conjugates. *Pharmaceutical Research*, 39(2), 456-465. <a href="Kanamycin BSA conjugate">https://pubmed.ncbi.nlm.nih.gov/?term=Kanamycin BSA conjugate</a> <br><strong>Products Related to Kanamycin BSA Conjugate can be found at</strong> <a href="https://moleculardepot.com/product-category/Conjugates/"> Conjugates</a>
Product Specifications
Short Description
Catalog Number: B2020691 (1 mg)
Weight
0.15
Length
2
Width
0.5
Height
0.5
Frequently Asked Questions
Explore Other Products
Browse additional items from our catalog